Olink News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.04.22	Erste Schätzungen: Olink legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
21.04.22	Olink to report first quarter 2022 financial results on May 12, 2022 (GlobeNewswire)
07.04.22	Report from the Annual General Meeting of Olink Holding AB (publ) on 7 April 2022 (GlobeNewswire)
17.03.22	Olink publishes 2021 annual report (GlobeNewswire)
09.03.22	TATAA Biocenter partners with Olink to add high quality proteomics with unrivaled throughput to their multi-omics offering (GlobeNewswire)
07.03.22	Notice to attend the Annual General Meeting of Olink Holding AB (publ) (GlobeNewswire)
07.03.22	THE NOMINATION COMMITTEE’S PROPOSAL FOR ELECTION OF MEMBERS OF THE BOARD OF DIRECTORS OF OLINK HOLDING AB (PUBL) (GlobeNewswire)
13.02.22	Ausblick: Olink verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
01.02.22	Olink to present at February investor conferences (GlobeNewswire)
30.01.22	Erste Schätzungen: Olink stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
20.01.22	Sequanta selects Olink® Explore 3072 to analyze new cohort study in China (GlobeNewswire)
10.01.22	Olink announces preliminary unaudited revenue for the fourth quarter and full year 2021 (GlobeNewswire)
04.01.22	Olink to present at the 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
06.12.21	Innovation and transparency at the heart of Olink’s culture – details of the technology behind the Olink Explore high-throughput proteomics platform published in the journal, Molecular & Cellular Prot (GlobeNewswire)
02.12.21	Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failure (GlobeNewswire)
01.12.21	Olink® Explore 3072 high-throughput proteomics platform now available: Significantly expands Olink's protein library for biomarker discovery (GlobeNewswire)
29.11.21	Melissa Amrein, at the University Hospital of Basel, Switzerland, is awarded the 2021 Novelties in Biomarkers prize at the Biomarkers of the Future Conference in Paris, France (GlobeNewswire)
23.11.21	Olink® Signature Q100 now available: A user friendly desktop instrument to broaden access to Olink’s multiplex protein analysis platform (GlobeNewswire)
11.11.21	Psomagen, Inc. is partnering with Olink Proteomics, enabling unprecedented multi-omics clinical studies (GlobeNewswire)
10.11.21	Olink reports third quarter 2021 financial results (GlobeNewswire)
05.11.21	Olink announces participation in November investor events (GlobeNewswire)
04.11.21	Fulgent Genetics Offers Multi-Omic Solutions to Pharma through Addition of Olink Proteomics Platform (GlobeNewswire)
20.10.21	Olink to report third quarter 2021 financial results on November 10, 2021 (GlobeNewswire)
01.09.21	Olink to present at two upcoming investor conferences (GlobeNewswire)
31.08.21	CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services (GlobeNewswire)
11.08.21	Olink reports second quarter 2021 financial results (GlobeNewswire)
27.07.21	Olink: CORAL to use the Olink Proteomics platform to identify novel protein biomarkers and biological mechanisms for neurological diseases (GlobeNewswire)
21.07.21	UK Biobank-PPP expands proteomics study of 53,000 participants to Olink Explore 3072 (GlobeNewswire)
15.07.21	Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by Selling Shareholders (GlobeNewswire)
13.07.21	Olink enters into an agreement with deCODE genetics for early access to the Olink Explore 3072 Platform (GlobeNewswire)
12.07.21	Olink announces preliminary financial results for the second quarter 2021 (GlobeNewswire)
12.07.21	Olink Holding AB (publ) Launches Public Offering of American Depositary Shares by Selling Shareholders (GlobeNewswire)
23.06.21	Olink announces the new Explore 3072 high throughput proteomics platform, offering uncompromised data quality with coverage of all major biological pathways (GlobeNewswire)
15.06.21	Olink: SCALLOP launches clinical trial arm to uncover next level of drug target insights from proteomic profiling (GlobeNewswire)
02.06.21	Announcing Olink Signature Q100: facilitating access for researchers to Olink technology with a benchtop system dedicated to multiplex protein biomarker measurement (GlobeNewswire)
25.05.21	Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference (GlobeNewswire)
20.05.21	Olink reports first quarter 2021 financial results and issues full year 2021 guidance (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Olink Holding AB (publ) (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten